Please use a PC Browser to access Register-Tadawul
How Investors Are Reacting To Cohu (COHU) Wider Losses, New Guidance and Fresh Shelf Registration
Cohu, Inc. COHU | 28.64 28.64 | +0.07% 0.00% Pre |
- Cohu, Inc. recently reported fourth-quarter 2025 results showing higher sales of US$122.23 million versus US$94.12 million a year earlier, but a wider quarterly net loss of US$22.49 million and continued losses for the full year, alongside new first-quarter 2026 sales guidance and completion of a multi-year share repurchase program.
- Just days after these results, Cohu filed an omnibus shelf registration covering common and preferred stock, debt securities, warrants, and units, giving the company broad flexibility to raise capital across multiple instruments if needed.
- Next, we’ll examine how Cohu’s wider losses, new guidance and fresh shelf registration could influence its longer-term investment narrative.
AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
Cohu Investment Narrative Recap
To own Cohu, you need to believe its test equipment portfolio can translate cyclical semiconductor demand into sustainable, profitable growth, despite recent losses and revenue volatility. The key near term catalyst remains execution on orders and design wins; the biggest current risk is that ongoing losses and concentrated customer exposure limit operating leverage. The latest earnings miss, modest Q1 2026 sales guidance and new shelf registration do not fundamentally change that risk reward balance in the short term.
The omnibus shelf registration filed shortly after earnings is the announcement that most directly frames this setup, because it expands Cohu’s options if it decides to reinforce the balance sheet or fund continued investment while still unprofitable. Set against higher sales but wider 2025 losses and flat Q1 2026 revenue guidance, this additional financing flexibility sits alongside the just completed US$117.17 million buyback as a key contextual factor for how any eventual upturn in orders could translate into shareholder outcomes.
Yet even with these financial tools in place, investors should be aware of how heavily Cohu still depends on a handful of large customers and what happens if...
Cohu's narrative projects $640.1 million revenue and $90.3 million earnings by 2028.
Uncover how Cohu's forecasts yield a $31.80 fair value, in line with its current price.
Exploring Other Perspectives
One Simply Wall St Community member currently pegs Cohu’s fair value at US$31.80, matching the analyst consensus, showing how even individual models can converge. You can compare that with the risk that Cohu’s early stage position in high growth computing test, including AI infrastructure, may limit how much of any future industry upswing actually reaches the company’s top line.
Explore another fair value estimate on Cohu - why the stock might be worth just $31.80!
Form Your Own Verdict
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Cohu research is our analysis highlighting 1 key reward that could impact your investment decision.
- Our free Cohu research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Cohu's overall financial health at a glance.
Ready For A Different Approach?
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
- Uncover the next big thing with 30 elite penny stocks that balance risk and reward.
- The future of work is here. Discover the 32 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
- Find 53 companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.


